GMV obtains permission to sell its planning of intraoperative radiotherapy in the United States system.UU

-(RIO) intraoperative radiotherapy treatment planning system, radiance ™, developed by GMV, is the perfect tool for simulation and planning for oncologists, radiation, surgeons, physicians and other professionals in the RIO

-obtaining this certification allows the marketing of radiance ™, in the restricted US market

Madrid, January 2011.- GMV, multinational engineering company leader in the development and implementation of innovation and advanced technologies, has officially received the notice from the FDA (Food and Drug Administration), administration of food and medicines from U.S., which authorizes you to market your specific treatment planning product for intra-operative radiotherapy, radiance ™, in the United States.UU.

The system, the first of its kind in the world, has been developed by GMV in collaboration with the team of researchers from the departments of Oncology and medicine and Experimental surgery in the Hospital Universitario Gregorio Marañón, led by Dr. Calvo, head of the Department of Oncology, and Dr. DescoHead of the Department of surgery and Experimental Medicine, along with a set of prestigious hospitals and universities.

radiance ™, recently presented with great success at the global level in the Hospital General Universitario Gregorio Marañón by own Dr. Felipe Calvo – who also departed the idea original, allows pre-planificar decisions of surgical intervention and the effects of radiation therapy applied to the patient in surgery, rather than a patient gets no doses of radiation.

It’s a safe and reliable method, which increases the accuracy and efficiency of the radiation in one operation, providing substantial benefits both patients, reducing the length of statements and improving their quality of life, as surgeons and oncologists, who may enter the operating room with many of the previously evaluated and agreed decisions.

The technological complexity of this and other developments of GMV, requires different standards of quality in its processes, that is why radiance ™ got the certification of brand EC, which authorizes its commercialization in all European Union Member States, and which has recently also managed the authorization of the Agency for food and medicine in the United States.UU., two most important markets RIO today allowing GMV to continue its process of promotion and expansion internationally.

GMV is a Spanish technology group founded in 1984, private capital and international presence. Opera in the sectors: aerospace, defence and security, transport, health, telecommunications and information technologies for large companies and PPAA. He earned revenues in 2010 of more than EUR 100 million, with a staff of more than 1,000 professionals. The company’s growth strategy is based on continuous innovation, devoting 10% of its turnover to r & d GMV has reached level 5 for CMMI, the most prestigious model of the world in terms of improving the capacity of an organization’s processes and has numerous international patents. Currently GMV is the first independent provider worldwide of ground Control systems for operators of commercial telecommunications satellites; the third European company by volume of participation in Galileo; the main provider of command and the army Spanish C3I control systems. In the sector ICT has led flagship projects in the development and implementation of portals and platforms of mail, has been on national as a provider of solutions and advanced security services in IP networks, mobility applications and applications ICT for public administration and development of the e-Administration.